Empagliflozin 25mg + Sitagliptin 100mg Tablets

Product Introduction

Empagliflozin 25mg + Sitagliptin 100mg combines empagliflozin, an SGLT2 inhibitor, with a DPP-4 inhibitor component for adults with type 2 diabetes for this dual mechanism treatment. Empagliflozin helps the kidneys remove excess glucose through urine, while the DPP-4 inhibitor supports incretin hormones that improve glucose-dependent insulin release and reduce glucagon after meals. This combination can help fasting and meal-related glucose patterns without directly acting like insulin. This treatment is for type 2 diabetes and is not used for type 1 diabetes or diabetic ketoacidosis.

How to use

Take Empagliflozin + Sitagliptin 25mg + 100mg once daily as prescribed, with or without food unless advised otherwise. Keep glucose monitoring, hydration, sick-day, surgery-hold, and kidney-test instructions.

How it works

Empagliflozin increases urinary glucose excretion by blocking SGLT2. The DPP-4 inhibitor prolongs incretin activity, improving meal-related insulin response and reducing glucagon when glucose is elevated.

Common side effects

Possible effects include increased urination, genital fungal infection, urinary infection, stuffy nose, headache, nausea, dizziness, and joint pain. Serious concerns include ketoacidosis, pancreatitis, severe allergic reaction, dehydration, kidney problems, and severe skin reaction.

Important information

Discuss kidney disease, pancreatitis, gallstones, heart failure, dehydration, recurrent urinary/genital infections, pregnancy, breastfeeding, surgery, fasting, ketogenic diet, insulin or sulfonylurea use, and severe joint pain history.